Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and ChinaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictionsFriday, August 9, 2024Availability, Epidemiological impactRead More
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in the U.S.Friday, August 9, 2024Availability, Epidemiological impactRead More
TB case-finding in the context of future vaccinesFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Is neglect of self-clearance biasing TB vaccine impact estimates?Friday, August 9, 2024Availability, Epidemiological impactRead More
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.Friday, August 9, 2024Availability, Epidemiological impactRead More
